Skip to Content

391 G (Carbidopa and Levodopa Extended Release 50 mg / 200 mg)

Pill with imprint 391 G is Purple, Elliptical / Oval and has been identified as Carbidopa and Levodopa Extended Release 50 mg / 200 mg. It is supplied by Global Pharmaceuticals.

Carbidopa/levodopa is used in the treatment of parkinson's disease; restless legs syndrome; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 50 mg / 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 391 G

Carbidopa and Levodopa Extended Release

Imprint:
391 G
Strength:
50 mg / 200 mg
Color:
Purple
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Global Pharmaceuticals
Inactive Ingredients:
hydroxypropyl cellulose
magnesium stearate
FD&C Blue No. 2
FD&C Red No. 40
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide